Largest real-world evidence study on Heavy Menstrual Bleeding using OMOP methodology performed across IQVIA and pharma’s own databases
Largest real-world evidence study on Heavy Menstrual Bleeding using OMOP methodology performed across IQVIA and pharma’s own databases
2 PagesIQVIA conducted the largest RWE study on heavy menstrual bleeding (HMB) across five data sources in four countries using the OMOP framework. The study analyzed treatment pathways of women diagnosed with HMB (2000–2020), finding low diagnosis and delayed treatment despite guideline-recommended LNG-IUDs. Results showed significant variation in treatment across countries and frequent under-treatment. IQVIA developed reusable analytics packages, enabling the client to replicate studies across databases and publish high-impact findings that inform care gaps and policy.
